Elucidating gsk-3 substrate and inhibitor binding sites as a tool for inhibitor refinement

被引：0
|
作者：
Licht-murava, A. [1 ]
Plotkin, B. [1 ]
Eisenstein, M. [2 ]
Eldar-Finkelman, H. [1 ]
机构：
[1] Tel Aviv Univ, IL-69978 Tel Aviv, Israel
[2] Weizmann Inst Sci, IL-76100 Rehovot, Israel
来源：
MOLECULAR BIOLOGY OF THE CELL | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
1485
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Elucidating Substrate and Inhibitor Binding Sites on the Surface of GSK-3β and the Refinement of a Competitive Inhibitor
    Licht-Murava, Avital
    Plotkin, Batya
    Eisenstein, Miriam
    Eldar-Finkelman, Hagit
    JOURNAL OF MOLECULAR BIOLOGY, 2011, 408 (02) : 366 - 378
  • [2] Elucidating the relationship between substrate and inhibitor binding to the active sites of tetrameric β-galactosidase
    Mogalisetti, Pratyusha
    Gorris, Hans H.
    Rojek, Marcin J.
    Walt, David R.
    CHEMICAL SCIENCE, 2014, 5 (11) : 4467 - 4473
  • [3] Activator or inhibitor? GSK-3 as a new drug target
    Takahashi-Yanaga, Fumi
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (02) : 191 - 199
  • [4] Acceleration of bone regeneration by topical application of GSK-3 inhibitor
    Arioka, Masaki
    Takahashi, Fumi
    Sasaki, Masanori
    Sasaguri, Toshiyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 95P - 95P
  • [5] The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes
    Tseng, Ai-Sun
    Engel, Felix B.
    Keating, Mark T.
    CHEMISTRY & BIOLOGY, 2006, 13 (09): : 957 - 963
  • [6] GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
    Yost, C
    Farr, GH
    Pierce, SB
    Ferkey, DM
    Chen, MM
    Kimelman, D
    CELL, 1998, 93 (06) : 1031 - 1041
  • [7] Pim Kinase Inhibitor Enhances FLT3 Inhibitor Efficacy through GSK-3β Activation and GSK-3β-Mediated Proteasomal Degradation of c-Myc
    Lee, Jonelle K.
    Scarpa, Mario
    Chatterjee, Aditi
    Ali, Moaath Mustafa
    Singh, Prerna
    Kapoor, Shivani
    Trotta, Rossana
    Baer, Maria R.
    BLOOD, 2021, 138
  • [8] Novel GSK-3 kinase inhibitor Pym-5 induces GSK-3β rather than GSK-3α-dependent melanogenesis in murine melanoma cells
    Jia, Qi
    Tao, Li
    Zhou, Yinyin
    Song, Li
    Wei, Zhonghong
    Lu, Tao
    Woodgett, James R.
    Lu, Yin
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2022, 106 (03) : 170 - 180
  • [9] A novel GSK-3 inhibitor binds to GSK-3β via a reversible, time and Cys-199-dependent mechanism
    Ghazanfari, Davoud
    Noori, Mahboubeh S.
    Bergmeier, Stephen C.
    Hines, Jennifer, V
    McCall, Kelly D.
    Goetz, Douglas J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 40
  • [10] Antitumor effect of a novel GSK-3 inhibitor on urothelial cancer cells
    Kuroki, Hiroo
    Anraku, Tsutomu
    Bilim, Vladimir
    Ugolkov, Andrey
    Tasaki, Masayuki
    Takizawa, Itsuhiro
    Tomita, Yoshihiko
    CANCER SCIENCE, 2018, 109 : 303 - 303
12345